INTRODUCTION AND OBJECTIVE: Recent studies have shown an inverse relationship with
serum PSA levels and body mass index (BMI). We examined the relationship of BMI and …

INTRODUCTION AND OBJECTIVE: Recent studies have shown an inverse relationship with
serum PSA levels and body mass index (BMI). We examined the relationship of BMI and …

BACKGROUND Differential prostate‐specific antigen (PSA) testing practices according to
obesity‐related comorbid conditions may contribute to inconsistent results in studies of …

BACKGROUND: Previous studies suggest that obesity is associated with higher prostate
cancer progression and mortality despite an association with lower prostate cancer …

OBJECTIVE To determine if lower serum total prostate specific antigen (PSA) levels in
obese American men affect prostate‐cancer screening results, as an increased body mass …

This study was designed to use a prospectively analyzed, population-based, multiethnic
cohort of men to determine if there is a relationship between one measure of …

PURPOSE: Obesity has been associated with lower serum testosterone, theoretically
resulting in decreased PSA production. Obesity has also been associated with prostatic …

Purpose: Obesity is associated with more advanced disease and worse outcomes in men
with prostate cancer. To our knowledge the relationship between obesity and prostate …

OBJECTIVES: Studies suggest obesity is associated with decreased prostate cancer risk.
We hypothesized obesity is biologically associated with increased risk, although this is …

OBJECTIVE: To examine the association of obesity with the prebiopsy prostate-specific
antigen (PSA), Gleason score, clinical stage, and D'Amico tumor risk in 2 independent …